|
2022 |
Lease of Venue for the Conduct of Regional Epidemiology and Surveillance Units (RESUs) and Health Promotion Units (HPUs) Consultative Workshop on Online National Electronic Injury Surveillance System (ONEISS) |
GOP-EB-2022-002 |
ZURI HOTELS & SUITES |
October 14, 2022 |
November 18, 2022 |
|
2022 |
Procurement of Etonogestrel |
IB No. 2022-147 |
Zuellig Pharma Corporation-Interphil Laboratories, Inc., Joint Venture |
September 21, 2022 |
September 23, 2022 |
|
2021 |
PROCUREMENT OF BEDAQUILINE |
IB NO. 2021-179 |
Zuellig Pharma Corporation – Interphil Laboratories Inc., Joint Venture |
July 26, 2021 |
July 26, 2021 |
|
2021 |
PROCUREMENTOF RIFAMPICIN + ISONIAZID |
IB NO. 2021-198 |
Zuellig Pharma Corporation – Interphil Laboratories Inc., Joint Venture |
September 29, 2021 |
October 15, 2021 |
|
2023- |
PROCUREMENT OF ASPARAGINASE |
IB NO.2023-052 |
Zuellig Pharma Corporation – Interphil Laboratories Inc., Joint Venture |
March 6, 2023 |
March 8, 2023 |
|
2021 |
PROCUREMENT OF HUMAN PAPILLOMA VIRUS VACCINE |
IB NO. 2021-186 |
Zuellig Pharma Corporation – Interphil Laboratories Inc., Joint Venture |
December 15, 2021 |
December 16, 2021 |
|
2021 |
Procurement of Pneumococcal Polyvalent Vaccine – Rebid |
IB No. 2021-102-A |
Zuellig Pharma Corporation – Interphil Laboratories Inc., Joint Venture |
June 3, 2021 |
June 7, 2021 |
|
2022 |
Procurement of Inactivated Polio Vaccine |
IB No. 2022-272 |
Zuellig Pharma Corporation - Interphil Laboratories, Inc., Joint Venture |
December 28, 2022 |
December 28, 2022 |
|
2022 |
Procurement of Bedaquiline |
IB No. 2022-151 |
Zuellig Pharma Corporation - Interphil Laboratories, Inc., Joint Venture |
May 18, 2022 |
May 24, 2022 |
|
2023 |
Procurement of Rituximab |
IB No. 2023-085 |
Zuellig Pharma Corporation - Interphil Laboratories, Inc., Joint Venture |
March 9, 2023 |
March 11, 2023 |
